Ahn-Gook Pharmaceutical Co., Ltd. (001540) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ahn-Gook Pharmaceutical Co., Ltd. (001540:KRX), powered by AI.

Current Price
₩10,200
P/E Ratio
17.8
Market Cap
133.0B
Sector
Healthcare
What is the Ahn-Gook Pharmaceutical Co., Ltd. stock price forecast?

Ahn-Gook Pharmaceutical Co., Ltd. is currently trading at ₩10,200. View real-time AI analysis on Alpha Lenz.

What is Ahn-Gook Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Ahn-Gook Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Ahn-Gook Pharmaceutical Co., Ltd.'s P/E ratio?

Ahn-Gook Pharmaceutical Co., Ltd.'s P/E ratio is 17.8.

Ahn-Gook Pharmaceutical Co., Ltd.

KRX · 001540
₩10,200+2,350(+29.94%)Market closedKRX regular session 09:00–15:30 KST
Ask about Ahn-Gook Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Ahn-Gook Pharmaceutical Co., Ltd. trades at a P/E of 17.8 (fair value) with modest ROE of 4.5%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.

Ask for details

Company Overview

Ahn-Gook Pharmaceutical Co., Ltd. is a renowned company in the pharmaceutical industry, dedicated to the research, production, and distribution of a wide array of medicinal products. Since its inception, the company has been at the forefront of developing treatments that cater to both acute and chronic health conditions, enriching lives with its innovative healthcare solutions. The company's product line significantly impacts sectors such as cardiovascular, respiratory, and gastrointestinal medicine, offering life-saving drugs and long-term therapy options. With its strong emphasis on research and development, Ahn-Gook Pharmaceutical plays a crucial role in advancing medical science, fostering collaborations with academic institutions and healthcare organizations globally. Its commitment to quality assurance ensures safety and efficacy, bolstering trust among healthcare providers and patients alike. In the financial market, Ahn-Gook Pharmaceutical is a key player on the Korean Stock Exchange, representing the dynamic growth and resilience of South Korea's pharmaceutical sector. The company's steadfast dedication to health improvement and sustainable practices underscores its significant presence in the global healthcare landscape.

CEO어진, 박인철 (각자 대표)
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees402

Company Statistics

FY 2025

Profile

₩133,032,684,000Market Cap
₩306,873,904,370Revenue
13.04MShares Out
402Employees

Margins

65.27%Gross
6.18%EBITDA
3.20%Operating
2.51%Pre-Tax
2.39%Net

Valuation

17.78P/E
0.80P/B
0.43EV/Sales
8.87EV/EBITDA
3.59P/FCF

Growth (CAGR)

14.32%Rev 3Yr
16.44%Rev 5Yr
2.33%Op Inc 3Yr
59.51%Op Inc 5Yr
2.09%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

2.39%ROA
4.52%ROE
3.41%ROIC

Financial Health

₩38,948,596,320Cash & Cash Equivalents
₩105,714,560,100Net Debt
86.99%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ahn-Gook Pharmaceutical Co., Ltd. (ticker: 001540) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 402 employees. Market cap is $133.0B.

The current price is ₩10,200 with a P/E ratio of 17.78x and P/B of 0.8x.

ROE is 4.52% and operating margin is 3.20%. Annual revenue is $306.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ahn-Gook Pharmaceutical Co., Ltd. (001540) Stock Forecast 2026 ₩10,200 — Price, Financials & Analyst Targets | Alpha Lenz